
Laxmi Dental Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Thu Apr 09 2026

Laxmi Dental (NSE: LAXMIDENTAL) is preparing to announce its Q4 FY26 financial results for the period ended March 31, 2026. The board of directors is scheduled to meet in May 2026 (Expected) to approve the audited statements and consider a final dividend recommendation. With the stock at Rs 1,200 — against a 52-week high of Rs 1,620 and a 1-year return of -16% — the Q4 FY26 results will be a pivotal event for investors.
Analyst estimates for Q4 FY26 revenue stand at Rs 280-310 Cr, with PAT expectations of Rs 43-52 Cr and margin projections of EBITDA 20-22%. This article covers the Laxmi Dental Q4 results 2026 date, earnings estimates, five key performance factors, five risks, analyst ratings, and investor FAQs.
Laxmi Dental Q4 Results 2026 Date
Get free investment predictions and live Q4 result alerts on Univest.
| Company | Results Date | Article |
| TCS | April 9, 2026 | Preview on Univest |
| Infosys | April 23, 2026 | Preview on Univest |
| Laxmi Dental | May 2026 (Expected) | This article |
Why This Quarter Matters
Laxmi Dental enters Q4 FY26 with expectations of 15-20% YoY revenue growth. Q4 determines full-year FY26 performance, sets FY27 estimate baselines, and triggers final dividend announcements. At a 1-year return of -16%, this quarter’s results and FY27 guidance will be critical for determining stock trajectory.
Laxmi Dental Q4 FY26 Earnings Estimates

Laxmi Dental Q4 FY26 analyst estimates. Source: MOFSL, YES Securities, JM Financial.
Access premium SEBI-registered research on Univest.
| Metric | Q3 FY26 Actual | Q4 FY26 Estimate | Driver |
| Revenue | Rs 248 Cr | Rs 280-310 Cr | Volume + pricing |
| PAT | Rs 38 Cr | Rs 43-52 Cr | Operating leverage |
| Margin | EBITDA 20.4% | EBITDA 20-22% | Cost control |
| Key Growth Metric | Q3 trend | 15-20% YoY revenue growth | Management execution |
| Dividend Estimate | — | Rs 2-4 per share | Board recommendation |
Screen Laxmi Dental fundamentals on Univest Screener.
5 Key Factors That Will Drive Laxmi Dental Q4 FY26 Performance
Revenue Momentum
Analysts expect Rs 280-310 Cr in Q4 FY26 revenue versus Rs 248 Cr in Q3. Q4 is seasonally important for the Healthcare/Dental sector and the ability to convert the pipeline into recognised revenue will be the first performance test.
Margin Trajectory
Q4 FY26 margin expectations are EBITDA 20-22% versus EBITDA 20.4% in Q3. Input cost trends, employee expenses, and pricing power will determine whether the company can sustain or improve on Q3 levels.
PAT Quality
Net profit is estimated at Rs 43-52 Cr. Investors will assess whether PAT is driven by operational improvement or non-recurring items. A clean recurring profit print is most positively received by institutional investors.
Management Guidance for FY27
The most consequential output will be FY27 guidance — revenue growth bands, margin targets, and capex plans. Credible FY27 guidance carries significant weight for re-rating potential in the current macro environment.
Dividend Declaration
Laxmi Dental is expected to consider a final dividend of Rs 2-4 per share. The quantum signals management’s confidence in free cash flow generation and sets expectations for FY27 capital allocation.
5 Risks to Watch in Laxmi Dental Q4 FY26
US Tariff and Macro Headwinds
The 26% US reciprocal tariff on Indian goods has created macro uncertainty. For Laxmi Dental, indirect impacts include FII outflows and earnings estimate cuts if global demand slows.
Earnings Miss Risk
If Laxmi Dental’s Q4 FY26 results miss estimates, the stock could correct sharply. Investors should monitor revenue versus Rs 280-310 Cr and PAT versus Rs 43-52 Cr as the two primary watchpoints.
FY27 Guidance Below Consensus
If FY27 guidance falls below Street expectations, the stock may decline even if Q4 numbers are in line. Forward guidance carries more weight than the reported quarter currently.
FII Outflow Continuation
FIIs sold Rs 22,000 crore in Indian equities in a single week following the tariff announcement. Continued selling creates headwinds for Laxmi Dental regardless of fundamentals.
Sector Regulatory Risk
The Healthcare/Dental sector faces evolving regulatory frameworks. Policy changes that increase compliance costs or alter competitive dynamics could affect Laxmi Dental’s profitability.
Laxmi Dental Share Price and Analyst Ratings

Laxmi Dental share price snapshot and analyst ratings. Source: Brokerages, NSE data.
Laxmi Dental is trading at Rs 1,200 as of early April 2026, against a 52-week high of Rs 1,620 and a 52-week low of Rs 940. Market cap stands at Rs 7,200 Cr.
| Brokerage | Rating | Target Price | Thesis |
| MOFSL | Buy | Rs 1,550 | Dental prosthetics leader; B2B + export |
| YES Securities | Buy | Rs 1,520 | Digital dentistry + CAD/CAM transition |
| JM Financial | Add | Rs 1,450 | US + EU export + India dental chain |
| Emkay | Buy | Rs 1,480 | Unique dental product company India |
Download the Univest iOS App or Univest Android App to track Laxmi Dental live and receive real-time Q4 result alerts.
Conclusion
Laxmi Dental Q4 FY26 results on May 2026 (Expected) will be a key event for Healthcare/Dental sector investors. Analysts project PAT of Rs 43-52 Cr and revenue of Rs 280-310 Cr. At Rs 1,200 with analyst targets from Rs 1,480 to Rs 1,550, FY27 guidance will be the most critical post-results catalyst.
For more Q4 FY26 previews, visit Univest Blogs.
Frequently Asked Questions
What is the Laxmi Dental Q4 results 2026 date?
The Laxmi Dental Q4 results 2026 date is May 2026 (Expected). The board will meet to approve audited Q4 FY26 financials and consider a final dividend recommendation.
What is the Laxmi Dental Q4 FY26 PAT estimate?
Analysts estimate Laxmi Dental Q4 FY26 PAT at Rs 43-52 Cr, based on revenue of Rs 280-310 Cr and margin of EBITDA 20-22%.
What is Laxmi Dental’s share price ahead of Q4 results?
Laxmi Dental is trading at Rs 1,200. The 52-week high is Rs 1,620 and low is Rs 940. The 1-year return is -16% and market cap is Rs 7,200 Cr.
Will Laxmi Dental declare a dividend in Q4 FY26?
Laxmi Dental is expected to consider a final dividend of Rs 2-4 per share at the Q4 FY26 board meeting on May 2026 (Expected).
Which analysts have a Buy rating on Laxmi Dental?
MOFSL (Buy, Rs 1,550), YES Securities (Buy, Rs 1,520), JM Financial (Add, Rs 1,450), Emkay (Buy, Rs 1,480) have positive ratings heading into Q4 FY26.
What were Laxmi Dental Q3 FY26 results?
Laxmi Dental reported Q3 FY26 revenue of Rs 248 Cr and PAT of Rs 38 Cr, with margin at EBITDA 20.4%.
When do TCS and Infosys announce Q4 results 2026?
TCS declared Q4 FY26 results on April 9, 2026. Infosys Q4 FY26 results are scheduled for April 23, 2026. Read both previews on Univest Blogs.
Is Laxmi Dental a good investment ahead of Q4 results?
This depends on your risk appetite. Laxmi Dental has compelling long-term factors alongside genuine near-term risks. Consult a SEBI-registered financial advisor before investing.
Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only. All financial data and analyst estimates are sourced from publicly available information. Verify before investing. Consult a SEBI-registered advisor before making investment decisions.
Recent Article
TCS Share Price Target 2026 — Key Factors, Financial Performance & Analyst Forecast
Nestle India Share Price Target 2026 — Key Factors, Financial Performance & Analyst Forecast
State Bank of India Share Price Target 2026: Analyst Forecasts, Bull & Bear Case
Hindustan Unilever Share Price Target 2026 — Key Factors, Financial Performance & Analyst Forecast
Related Posts
Godrej Properties Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Firstsource Solutions Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Prestige Estates Projects Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Solara Active Pharma Sciences Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Thyrocare Technologies Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

